We’re back this week with an industry visionary who has spent the last 10 years leading marketing and training efforts in the Aesthetic Industry. After business school, Drew Fine spent 10 years at Eli Lilly honing his craft in Diabetes marketing before moving to Galderma, where in the course of his nearly 7 years there as VP of Marketing, he led multiple launches of new FDA approved products, played a major role in the development of GAIN, and in many ways, masterminded the rise to dominance of the Restylane, Dysport and Sculptra brands under the ownership of Nestle Skin Health. From there, he moved to Allergan as VP of Marketing for the Facial Injectable Portfolio for nearly two years where he had his hands in Juvederm, Botox and AMI marketing efforts. But now, he’s taking on a whole new challenge….
At the start of 2023, Drew was named the Chief Commercial Officer at Advanced MedAesthetic Partners. Since its inception in October ’22, AMP has experienced rapid growth, scaling from 7 to 21 practices in only a few short months. Why? Some may lump AMP into the same category as traditional “Private Equity,” but as Drew can attest, their model is different. They come alongside successful practices and partner for the long haul. His analogy of the Marriott Autograph collection is a good one- great practices get to keep the very essence of what makes them successful and unique in their local markets, much like the Autograph hotels, but they get to reap the benefits of having a sophisticated, structured corporate partner in the background who oversees the legal, technical, compliance and HR operations much like Marriott. It’s truly the best of both worlds!
AMP is led by Nicole Chiaramonte, a veteran entrepreneur who was a multi-Aesthetic clinic owner prior to taking the CEO reins. She and Drew share a similar vision to create a culture of appreciation, maintain a strong focus on the people who make up the business, and to be a source of value for both owners and their staff as they transition to the AMP family. AMP has assembled a leadership team with the right balance of aesthetic experience and outside perspective, and their vision for the company stays true to the goals of the industry: putting patients, people and practices ahead of profits.
Drew has been an advocate for solid training, something he focused on at both Galderma and Allergan, so it’s no surprise that a key part of AMP’s strategy is offering best-in-class training to both Providers and Staff. From the AMP fellowship to protocols and processes, employees at any AMP-owned practice have access to learn and grow within the organization. From Drew’s perspective, one of the benefits of partnering with AMP is the opportunities for staff. As the organization continues to scale, it unlocks the potential for regional directors and trainers, corporate and field positions that just aren’t an option in a privately-owned practice.
To hear Drew talk about the industry and where it’s headed is part of his magic. He sees the chess pieces before others know a game is even being played. What’s missing in our industry? In his opinion (and we share it here at FTR!), it’s about technology. First, it’s automating the lead gen to booking process so that patients can find practices anytime from anywhere, keeping the store front open 24-7 without the expense of human capital. It’s offering capabilities for patients to assess their own needs, buy what they want, book and come in without human intervention. Second, it’s data mining. It’s using data in sophisticated ways to make solid decisions for the practice, and at the scale of AMP, their access to large data sets across all geographies creates a serious advantage when it comes to Amplifying the Aesthetic Industry!
See All Podcast Episodes
